Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines

Cancer Research

Volumn 63, Issue 12, 2003, Pages 3317-3324

  Wang, Min ^a   Lemon, William J ^b   Liu, Gongjie ^a   Wang, Yian ^b   Iraqi, Fuad A ^c   Malkinson, Alvin M ^d   You, Ming ^a,b  

^a OHIO STATE UNIVERSITY   (United States)

^b USA   (United States)

^c INTERNATIONAL LIVESTOCK RESEARCH INSTITUTE   (Kenya)

^d UNIVERSITY OF COLORADO CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLELISM; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER GENETICS; CONTROLLED STUDY; GENE; GENE LOCUS; GENE MAPPING; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; INBRED STRAIN; KRAS2 GENE; LUNG ADENOMA; LUNG CARCINOGENESIS; MOLECULAR CLONING; MOUSE; MOUSE STRAIN; NONHUMAN; NUCLEOTIDE SEQUENCE; PAS1 GENE; PAS1C1 GENE; PAS2 GENE; PAS3 GENE; PRIORITY JOURNAL; QUANTITATIVE TRAIT LOCUS;

ADENOMA; ANIMALS; CHROMOSOME MAPPING; CROSSES, GENETIC; GENE EXPRESSION PROFILING; GENES, RAS; GENETIC PREDISPOSITION TO DISEASE; IMMUNITY, NATURAL; LOD SCORE; LUNG NEOPLASMS; MICE; MICE, INBRED A; MICE, INBRED C57BL; POLYMORPHISM, SINGLE NUCLEOTIDE; QUANTITATIVE TRAIT LOCI; REGRESSION ANALYSIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SOFTWARE; URETHANE;

EID: 0038068943     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Fielding, J. E., Smoking: health effects and control. N. Engl. J. Med., 313: 491-498, 1985.
2. Doll, R., and Hill, A. B. A. study of the aeotiology of carcinoma of the lung. Br. Med. J., 2: 1271-1286, 1952.
3. Sellers T. A., Bailey-Wilson J. E., Elston, R. C., Wilson A. F., Elston, G. Z., Ooi, W. L., and Rothschild, H. Evidence for mendelian inheritance in the pathogenesis of lung cancer. J. Natl. Cancer Inst., 82: 1272-1279, 1990.
4. Sellers, T. A., Potter, J. D., and Folsom, A. R. Association of incident lung cancer with family history of female reproductive cancers: the Iowa Women's Health Study. Genet. Epidemiol. 8: 199-208, 1991.
5. Sellers, T. A., Elston, R. C., Atwood, L. D., and Rothschild, H. Lung cancer histologic type and family history of cancer. Cancer (Phila.), 69: 86-91, 1992.
6. Shimkin M. B. and Stoner G. D. Lung tumors in mice: application to carcinogenesis bioassay. Adv. Cancer Res., 21: 1-58, 1975.
7. Malkinson, A. M. The genetic basis of susceptibility to lung tumors in mice. Toxicology, 54: 241-271, 1989.
8. Gariboldi, M., Manenti, G., Canzian, F., Falvella, F. S., Radice, M. T., Pierotti, M. A., Della Porta, G., Binelli, G., and Dragani, T. A. A. major susceptibility locus to murine lung carcinogenesis maps on chromosome 6. Nat. Genet., 3: 132-136, 1993.
9. Festing, M. F., Yang, A., and Malkinson, A. M. At least four genes and sex are associated with susceptibility to urethane-induced pulmonary adenomas in mice. Genet. Res., 64: 99-106, 1994.
10. Devereux, T. R., Wiseman, R. W., Kaplan, N., Garren, S., Foley, J. F., White, C. M., Anna, C., Watson, M. A., Patel, A., and Jarchow, S. Assignment of a locus for mouse lung tumor susceptibility to proximal chromosome 19. Mamm. Genome, 5: 749-755, 1994.
11. Manenti, G., Falvella, F. S., Gariboldi, M., Dragani, T. A., and Pierotti, M. A. Different susceptibility to lung tumorigenesis in mice with an identical Kras2 intron 2. Genomics, 29: 438-444, 1995.
12. Lin, L., Festing, M. F., Devereux, T. R., Crist, K. A., Christiansen, S. C., Wang, Y., Yang, A., Svenson, K., Paigen, B., Malkinson, A. M., and You, M. Additional evidence that the K-ras protooncogene is a candidate for the major mouse pulmonary adenoma susceptibility (Pas-1) gene. Exp. Lung Res., 24: 481-497, 1998.
13. Fijneman, R. J., de Vries, S. S., Jansen, R. C., and Demant, P. Complex interactions of new quantitative trait loci. Sluc1, Sluc2, Sluc3, and Sluc4, that influence the susceptibility to lung cancer in the mouse. Nat. Genet., 14: 465-467, 1996.
14. Fijneman, R. J., van der Valk, M. A., and Demant, P. Genetics of quantitative and qualitative aspects of lung tumorigenesis in the mouse: multiple interacting Susceptibility in lung cancer (Sluc) genes wild large effects. Exp. Lung Res., 24: 419-436, 1998.
15. Fijneman, R. J., Jansen, R. C., van der Valk, M. A., and Demant. P. High frequency of interactions between lung cancer susceptibility genes in the mouse: mapping of Sluc5 to Sluc14. Cancer Res., 58: 4794-4798, 1998.
16. Tripodis, N., Hart, A. A., Fijneman, R. J., and Demant, P. Complexity of lung cancer modifiers: mapping of thirty genes and twenty-five interactions in balf of the mouse genome. J. Natl. Cancer Inst., 93: 1484-1491, 2001.
17. Darvasi, A. Experimental strategies for the genetic dissection of complex traits in animal models. Nat. Genet., 18: 19-24, 1998.
18. Darvasi, A., and Soller, M. Advanced intercross lines, an experimental population for fine genetic mapping. Genetics, 141: 1199-1207, 1995.
19. Iraqi, F., Clapcott, S. J., Kumari, P., Haley, C. S., Kemp, S. J., and Teale, A. J. Fine mapping of trypanosomiasis resistance loci in murine advanced intercross lines. Mamm. Genome, 11: 645-648, 2000.
20. Lemon, W. J., Bernert, H., Sun, H., Wang, Y., and You, M. Identification of candidate lung cancer susceptibility genes in mice using oligonucleotide arrays. J. Med. Genet., 39: 639-643, 2002.
21. Lemon, W. J., Swinton C. H., Wang M., Berbari N., Wang Y., and You M. SNP analysis of mouse pulmonary adenoma susceptibility loci 1-4 for identification of candidate genes. J. Med. Genet., in press, 2003.
22. Pataer, A., Nishimura, M., Kamoto, T., Ichioka, K., Salo, M., and Hiai, H. Genetic resistance to urethan-induced pulmonary adenomas in SMXA recombinant inbred mouse strains. Cancer Res., 57: 2904-2908, 1997.
23. Behrens, T. W., Jagadeesh, J., Scherle, P., Kearns, G., Yewdell, J., and Staudt, L. M. Jawl. A lymphoid-restricted membrane protein legalized to the endoplasmic reticulum. J. Immunol., 153: 682-690, 1994.
24. Dragani, T. A., Hirohashi, S., Juji, T., Kawajiri, K., Kihara, M., Ono-Kihara, M., Manenti, G., Nomoto, T., Sugimura, H., Genka, K., Yokota, J., Takahashi, T., Mitsudomi, T., and Nagao, M. Population-based mapping of pulmonary adenoma susceptibility I locus. Cancer Res., 60: 5017-5020, 2000.
25. Manenti, G., De Gregorio, L., Pitolli, S., Falvella, F. S., Incarbone, M., Ravagnani, F., Pierotti, M. A., and Dragani, T. A. Association of chromosome 12p genetic polymorphisms with lung adenocarcinoma risk and prognosis. Carcinogenesis (Lond)., 18: 1917-1920, 1997.
26. Waterston, R. H., Lindblad-Toh, K., Birney, E., Rogers, J., Abril, J. F., Agarwal, P., Initial sequencing and comparative analysis of the mouse genome. Nature (Lond.), 420: 520-562, 2002.
27. Herzog, C. R., Lubel, R. A., and You. M. Genetic epigenetic alterations in mouse lung tumors: implications for cancer chemoprevention. J. Cell Biochem., 28/29S: 49-63. 1997.
28. You, M., and Bergman. G. Preclinical and clinical models of lung cancer chemoprevention. Hematol. Oncol. Clin N. Am., 12: 1037-1053, 1998.
29. Zhang, Z., Wang, Y., Vikis, H. G., Johnson, L., Anderson, M. W., Sills, R. C., Devereux, T. R., Jacks, T., Guan, K. L., and You, M. Wild-type K-Ras can inhibit lung carcinogenesis in mice. Nat. Genet., 29: 25-33,. 2001.
30. Snyder, H. L., Bacik, I., Bennink, J. R., Kearns, G., Behrens, T. W., Bachi, T., Orlowski, M., and Yewdell, J. W. Two novel routes of transporter associated with antigen processing (TAP)-independent major histocompatibility complex class 1 antigen processing. J. Exp Med., 186: 1087-1098, 1997.
31. Behrens, T. W., Kearns, G. M., Rivard, J. J., Bernstein, H. D., Yewdell, J. W., and Staudt, L. M. Carboxyl-terminal targeting and novel post-translational processing of JAW1, a lymphoid protein of the endoplasmic reticulum. J. Biol. Chem., 271: 23528-23534, 1996.
32. Mostert, M. C., Verkerk, A. J., van de Pol, M., Heighway, J., Marynen, P., Rosenberg, C., van Kessel, A. G., van Echten, J., de Jong, B., Oosterhuis, J. W., and Looijenga, L. H. Identification of the critical region of 12p over-representation in testicular germ cell tumors of adolescents and adults. Oncogene, 16: 2617-2627, 1998.
33. Liu, H. X., Cartegni, L. Zhang, M. Q., and Krainer, A. R. A. mechanism for exon skipping caused by nonsense or missense mutations in BRCA1 and other genes. Nat. Genet., 27: 55-58. 2001.
34. Benvenisty, N., Leder, A., Kuo, A., and Leder, P. An embryonically expressed gene is a larger for c-Myc regulation via the e-Myc-binding sequence. Genes Dev., 6: 2513-2523, 1992.
35. Crosbie, R. H., Lim, L. E., Moore, S. A., Hirano, M. Hays, A. P., Maybaum, S. W., Collin, H., Dovico, S. A., Stolle, C. A., Fardeau, M., Tome, F. M., and Campbell, K. P. Molecular and genetic characterization of sarcospan: insights into sarcoglycan-sarcospan interactions. Hum. Mol. Genet, 9: 2019-2027, 2000.
36. Heighway, J., Betticher, D. C., Hoban, P. R., Altermatl, H. J. and Cowen R. Coamplification in tumors of KRAS2, type 2 inositol 1, 4, 5 triphosphate receptor gene, and a novel human gene, KRAG. Genomics, 35: 207-214, 1996.